benzphetamine (didrex) Report issue

Small molecule Approved FDA
ChEMBL DrugBank Drug Central Drugs@FDA MeSH PubChem repoDB

Active Ingredient History

NOW
  • Now
Benzphetamine is a substituted amphetamine used short-term along with a doctor-approved, reduced-calorie diet, exercise, and behavioral program for weight loss. It is prescribed for obesity to people who have been unable to lose weight through exercise and dieting alone. It is a prodrug to dextroamphetamine and dextromethamphetamine.   Wikipedia

Chemistry

More Chemistry

Pharmacology

Alternative names

(alphas)-n,alpha-dimethylphenethylamine | benzaphetamine | benzfetamina | benzfetamine | benzfetaminum | benzphetamine | (+)-benzphetamine | benzphetamine chloride | benzphetamine hcl | benzphetamine hydrochloride | benzylamphetamine | benzylamphetamine, (-)-isomer | benzylamphetamine, (+)-isomer | desmethylbenzphetamine | didrex | d-n-methyl-n-benzyl-beta-phenylisopropylamine | d-n-methyl-n-benzyl-β-phenylisopropylamine | (+)-n,alpha-dimethyl-n-(phenylmethyl)-benzeneethanamine | n-benzylamphetamine | (+)-n-benzyl-n,alpha-dimethylphenethylamine | (+)-n-benzyl-n,α-dimethylphenethylamine | n-methyl-1-phenyl-n-(phenylmethyl)propan-2-amine | (+)-n,α-dimethyl-n-(phenylmethyl)-benzeneethanamine | (s)-benzphetamine | (s)-(+)-benzphetamine | (s)-(+)-n-benzyl-n,alpha-dimethylphenethylamine | (s)-(+)-n-benzyl-n,α-dimethylphenethylamine

Organizations (15)

Research & Development (0)

Organization Org Type FDA approvals Clinical Trials involvement Org ID Force Sort

Marketing (15)

Organization Org Type FDA approvals Clinical Trials involvement Org ID Force Sort

Indications (1)

Approved Indications (1)


 

Obesity (approved 2006)

Experimental Indications - Clinical Trial Phases 1-4 (0)

Feedback

Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).

Report issue